Back to top

Image: Bigstock

Kimberly-Clark (KMB) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Read MoreHide Full Article

Kimberly-Clark (KMB - Free Report) reported $5.15 billion in revenue for the quarter ended March 2024, representing a year-over-year decline of 0.9%. EPS of $2.01 for the same period compares to $1.67 a year ago.

The reported revenue represents a surprise of +1.44% over the Zacks Consensus Estimate of $5.08 billion. With the consensus EPS estimate being $1.61, the EPS surprise was +24.84%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Kimberly-Clark performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Personal Care - Volume impact - YoY change: 2% compared to the 0.2% average estimate based on four analysts.
  • K-C Professional - Organic Sales Growth - YoY change: 2% versus -0.8% estimated by four analysts on average.
  • Personal Care - Organic Sales Growth - YoY change: 10% compared to the 4.7% average estimate based on four analysts.
  • Total Organic Sales Growth - YoY change: 6% versus 2.4% estimated by four analysts on average.
  • K-C Professional - Currency impact - YoY change: -2% versus the four-analyst average estimate of -2.7%.
  • Personal Care - Net price impact - YoY change: 7% versus the four-analyst average estimate of 3.6%.
  • Personal Care - Mix impact - YoY change: 1% versus the four-analyst average estimate of 0.9%.
  • Personal Care - Currency impact - YoY change: -9% compared to the -4.1% average estimate based on four analysts.
  • Net Sales- Personal Care: $2.71 billion versus $2.72 billion estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +0.3% change.
  • Net Sales- K-C Professional: $823 million compared to the $801.30 million average estimate based on four analysts. The reported number represents a change of -2.8% year over year.
  • Net Sales- Corporate & Other: $14 million versus $10.08 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +40% change.
  • Net Sales- Consumer Tissue: $1.60 billion versus $1.54 billion estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -2.1% change.
View all Key Company Metrics for Kimberly-Clark here>>>

Shares of Kimberly-Clark have returned +3% over the past month versus the Zacks S&P 500 composite's -4.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Kimberly-Clark Corporation (KMB) - free report >>

Published in